|
1
|
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.
|
Ann Intern Med
|
2014
|
12.79
|
|
2
|
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
|
Lancet
|
2009
|
11.81
|
|
3
|
Major lipids, apolipoproteins, and risk of vascular disease.
|
JAMA
|
2009
|
10.58
|
|
4
|
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies.
|
Lancet
|
2011
|
9.07
|
|
5
|
C-reactive protein, fibrinogen, and cardiovascular disease prediction.
|
N Engl J Med
|
2012
|
6.39
|
|
6
|
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
|
JAMA
|
2009
|
5.63
|
|
7
|
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.
|
Lancet
|
2010
|
5.31
|
|
8
|
Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis.
|
BMJ
|
2011
|
4.71
|
|
9
|
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies.
|
Lancet
|
2012
|
4.63
|
|
10
|
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents.
|
Lancet
|
2016
|
4.49
|
|
11
|
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
|
Lancet
|
2010
|
4.46
|
|
12
|
Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk.
|
JAMA
|
2008
|
4.21
|
|
13
|
Association of apolipoprotein E genotypes with lipid levels and coronary risk.
|
JAMA
|
2007
|
4.03
|
|
14
|
Lipid-related markers and cardiovascular disease prediction.
|
JAMA
|
2012
|
3.91
|
|
15
|
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data.
|
BMJ
|
2011
|
3.65
|
|
16
|
Genetic associations with valvular calcification and aortic stenosis.
|
N Engl J Med
|
2013
|
3.02
|
|
17
|
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database.
|
Circ Cardiovasc Imaging
|
2013
|
2.56
|
|
18
|
Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension.
|
J Hypertens
|
2014
|
2.54
|
|
19
|
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke.
|
Neurology
|
2013
|
2.26
|
|
20
|
Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants.
|
J Am Coll Cardiol
|
2010
|
2.20
|
|
21
|
Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data.
|
Arch Intern Med
|
2008
|
2.01
|
|
22
|
The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis.
|
PLoS One
|
2013
|
1.95
|
|
23
|
Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
|
Intensive Care Med
|
2005
|
1.83
|
|
24
|
N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS.
|
Eur Heart J
|
2012
|
1.55
|
|
25
|
Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis.
|
Eur Heart J
|
2013
|
1.53
|
|
26
|
The risk of paradoxical embolism (RoPE) study: initial description of the completed database.
|
Int J Stroke
|
2012
|
1.32
|
|
27
|
Association of the 9p21.3 locus with risk of first-ever myocardial infarction in Pakistanis: case-control study in South Asia and updated meta-analysis of Europeans.
|
Arterioscler Thromb Vasc Biol
|
2010
|
1.23
|
|
28
|
Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans.
|
Stroke
|
2004
|
1.22
|
|
29
|
N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease.
|
J Am Coll Cardiol
|
2011
|
1.18
|
|
30
|
Hemostatic factors and risk of coronary heart disease in general populations: new prospective study and updated meta-analyses.
|
PLoS One
|
2013
|
1.16
|
|
31
|
Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy.
|
Free Radic Biol Med
|
2006
|
1.08
|
|
32
|
The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial.
|
Trials
|
2014
|
1.04
|
|
33
|
Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors.
|
Cochrane Database Syst Rev
|
2014
|
0.99
|
|
34
|
Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study.
|
Heart
|
2006
|
0.97
|
|
35
|
Markers of inflammation and risk of coronary heart disease.
|
Dis Markers
|
2009
|
0.97
|
|
36
|
Phosphodiesterase 4D and 5-lipoxygenase activating protein genes and risk of ischemic stroke in Sardinians.
|
Eur J Hum Genet
|
2009
|
0.97
|
|
37
|
Genetic determinants of major blood lipids in Pakistanis compared with Europeans.
|
Circ Cardiovasc Genet
|
2010
|
0.95
|
|
38
|
Gene polymorphisms of the renin-angiotensin-aldosterone system and the risk of ischemic stroke: a role of the A1166C/AT1 gene variant.
|
J Hypertens
|
2004
|
0.93
|
|
39
|
Feasibility and clinical utility of transesophageal echocardiography in the acute phase of cerebral ischemia.
|
Am J Cardiol
|
2010
|
0.92
|
|
40
|
Reduced risk of myocardial infarction related to active commuting: inflammatory and haemostatic effects are potential major mediating mechanisms.
|
Eur J Cardiovasc Prev Rehabil
|
2010
|
0.90
|
|
41
|
Usefulness of tricuspid annular velocity in identifying global RV dysfunction in patients with primary pulmonary hypertension: a comparison with 3D echo-derived right ventricular ejection fraction.
|
Echocardiography
|
2008
|
0.90
|
|
42
|
Haemostatic and inflammatory markers are independently associated with myocardial infarction in men and women.
|
Thromb Res
|
2011
|
0.90
|
|
43
|
Long-term prognostic significance of three-dimensional echocardiographic parameters of the left ventricle and left atrium.
|
Eur J Echocardiogr
|
2009
|
0.89
|
|
44
|
Relation of left atrial maximal volume measured by real-time 3D echocardiography to demographic, clinical, and Doppler variables.
|
Am J Cardiol
|
2008
|
0.86
|
|
45
|
NT-proBNP is associated with coronary heart disease risk in healthy older women but fails to enhance prediction beyond established risk factors: results from the British Women's Heart and Health Study.
|
Atherosclerosis
|
2009
|
0.85
|
|
46
|
Neuroimaging findings in cryptogenic stroke patients with and without patent foramen ovale.
|
Stroke
|
2013
|
0.84
|
|
47
|
Beta2-adrenergic receptor gene polymorphisms and risk of ischemic stroke.
|
Am J Hypertens
|
2007
|
0.84
|
|
48
|
Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation.
|
Am J Cardiol
|
2007
|
0.83
|
|
49
|
Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism.
|
Arch Cardiovasc Dis
|
2010
|
0.83
|
|
50
|
Short-term evolution (9 months) of aortic atheroma in patients with or without embolic events: a follow-up transoesophageal echocardiographic study.
|
Eur J Echocardiogr
|
2008
|
0.83
|
|
51
|
Types of stroke recurrence in patients with ischemic stroke: a substudy from the PRoFESS trial.
|
Int J Stroke
|
2013
|
0.82
|
|
52
|
C-reactive protein and transesophageal echocardiographic markers of thromboembolism in patients with atrial fibrillation.
|
Int J Cardiol
|
2011
|
0.81
|
|
53
|
Identification of professional scuba divers with patent foramen ovale at risk for decompression illness.
|
Am J Cardiol
|
2004
|
0.81
|
|
54
|
Development and validation of a clinical and computerised decision support system for management of hypertension (DSS-HTN) at a primary health care (PHC) setting.
|
PLoS One
|
2013
|
0.81
|
|
55
|
Clinical utility of genetic variants for cardiovascular risk prediction: a futile exercise or insufficient data?
|
Circ Cardiovasc Genet
|
2012
|
0.81
|
|
56
|
Reciprocal congenic lines for a major stroke QTL on rat chromosome 1.
|
Physiol Genomics
|
2006
|
0.79
|
|
57
|
Feasibility and clinical impact of live three-dimensional echocardiography in the management of congenital heart disease.
|
Echocardiography
|
2006
|
0.79
|
|
58
|
High preoperative recipient plasma 7beta-hydroxycholesterol is associated with initial poor graft function after liver transplantation.
|
Liver Transpl
|
2005
|
0.79
|
|
59
|
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis.
|
Lancet Diabetes Endocrinol
|
2016
|
0.78
|
|
60
|
Association of dietary, circulating, and supplement fatty acids with coronary risk. In response.
|
Ann Intern Med
|
2014
|
0.78
|
|
61
|
Is the aortic root dilated in obstructive sleep apnoea syndrome?
|
Arch Cardiovasc Dis
|
2008
|
0.78
|
|
62
|
Circulating procoagulant microparticles in acute pulmonary embolism: a case-control study.
|
Int J Cardiol
|
2009
|
0.78
|
|
63
|
Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population.
|
Thromb Haemost
|
2005
|
0.77
|
|
64
|
Tomographic left ventricular volumetric emptying analysis by real-time 3-dimensional echocardiography: influence of left ventricular dysfunction with and without electrical dyssynchrony.
|
Circ Cardiovasc Imaging
|
2008
|
0.77
|
|
65
|
The Bangladesh Risk of Acute Vascular Events (BRAVE) Study: objectives and design.
|
Eur J Epidemiol
|
2015
|
0.77
|
|
66
|
D-dimers in atrial fibrillation: a further step in risk stratification of thrombo-embolism?
|
Eur Heart J
|
2007
|
0.75
|
|
67
|
Mechanisms of thrombogenesis in atrial fibrillation.
|
Lancet
|
2009
|
0.75
|
|
68
|
Should all patients with non-valvular atrial fibrillation be anticoagulated?
|
Int J Cardiol
|
2010
|
0.75
|
|
69
|
Spontaneous multiple cervical artery dissection: two case reports and a review of the literature.
|
J Emerg Med
|
2004
|
0.75
|
|
70
|
C-reactive protein and vascular risk: from March to Jupiter.
|
Arch Cardiovasc Dis
|
2010
|
0.75
|
|
71
|
Distribution of potential cardiac sources of embolism in young and older stroke patients: implications for recurrent vascular events.
|
J Cardiovasc Med (Hagerstown)
|
2006
|
0.75
|
|
72
|
REPEATED MEASUREMENTS OF BLOOD PRESSURE AND CHOLESTEROL IMPROVES CARDIOVASCULAR DISEASE RISK PREDICTION: AN INDIVIDUAL-PARTICIPANT-DATA META-ANALYSIS.
|
Am J Epidemiol
|
2017
|
0.75
|